发明授权
- 专利标题: Chimeric IL-1 receptor type I antagonists
- 专利标题(中): 嵌合IL-1受体I型拮抗剂
-
申请号: US13812582申请日: 2011-07-29
-
公开(公告)号: US08853150B2公开(公告)日: 2014-10-07
- 发明人: Thomas M. Barnes , Jinzhao Hou , Bracken M. King
- 申请人: Thomas M. Barnes , Jinzhao Hou , Bracken M. King
- 申请人地址: US MA Cambridge
- 专利权人: Eleven Biotherapeutics, Inc.
- 当前专利权人: Eleven Biotherapeutics, Inc.
- 当前专利权人地址: US MA Cambridge
- 代理机构: Lando & Anastasi LLP
- 国际申请: PCT/US2011/045995 WO 20110729
- 国际公布: WO2012/016203 WO 20120202
- 主分类号: A61K38/17
- IPC分类号: A61K38/17 ; C07K14/715 ; C07K14/545 ; A61K38/00
摘要:
Featured herein are non-naturally occurring cytokine domains that can be used, inter alia, to modulate cellular signalling responsive to interleukin-1 receptor I (IL-1 RI), to treat disorders, and to detect and/or bind to cellular receptors, as well as other agents. Exemplary cytokine domains can contain amino acid residues from at least two parental cytokines domains, for example, receptor binding features, surface features, β strands, and loops from at least two parental cytokines domains.
公开/授权文献
- US20130209396A1 CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS 公开/授权日:2013-08-15
信息查询
IPC分类: